Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Updated: US Likely To Lose Its First Approver Advantage After FDA Layoffs
Apr 01 2025
•
By
Sarah Karlin-Smith
,
Elizabeth Orr
, and
Derrick Gingery
Europe may be the big winner after the Trump Administration's layoffs at FDA.
(Shutterstock)
More from US FDA
More from Pathways & Standards